Neurocrine Biosciences (NBIX) Tops Q3 EPS by 28c
Tweet
Share
E-mail
Get Alerts NBIX Hot Sheet
Price: $139.49 --0%
Revenue Growth %: +30.8%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Revenue Growth %: +30.8%
Financial Fact:
Research and development: 20.94M
Today's EPS Names:
LGCY, UXIN, SCHL, More
Join SI Premium – FREE
Neurocrine Biosciences (NASDAQ: NBIX) reported Q3 EPS of $1.08, $0.28 better than the analyst estimate of $0.80. Revenue for the quarter came in at $387.9 million versus the consensus estimate of $376.55 million.
For earnings history and earnings-related data on Neurocrine Biosciences (NBIX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wall Street sees Muse as Meta’s next big catalyst after Connect event
- NeoVolta Inc. (NEOV) Misses Q3 EPS by 17c
- Darden Restaurants (DRI) Reports In-Line Q1 EPS, Misses on Revenue; Offers FY27 EPS Guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
